BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 6, 2017
View Archived Issues
EMA grants SPK-9001 access to PRIME program for hemophilia B
Read More
Melinta and Menarini sign development and commercialization agreement for delafloxacin
Read More
EMA grants orphan drug designation to Resolaris for limb girdle muscular dystrophy
Read More
Theratechnologies acquires commercial rights to ibalizumab in E.U. and other countries
Read More
C5aR1 as a potential new therapeutic target in Gaucher disease
Read More
FDA approves Noctiva for nocturnal polyuria
Read More
Chemotherapy-induced pyrimidine synthesis provides a target for triple-negative breast cancer
Read More
Santen Pharmaceutical and Singapore Eye Research Institute launch 5-year ophthalmic collaboration
Read More
PRC2 and BET bromodomain proteins as therapeutic targets for diffuse intrinsic pontine gliomas
Read More
Amryt completes phase III discussions with FDA and EMA for AP-101 in epidermolysis bullosa
Read More
Phase I study of Lymfactin advances to highest dose level
Read More
Cabozantinib S-malate from Exelixis granted U.S. orphan drug designation for the treatment of HCC
Read More
Vernalis and Servier establish new 2-year oncology drug discovery collaboration
Read More
TiGenix updates progress of European MAA procedure for Cx-601
Read More
Genetic analyses of phase II studies of Qbeco in Crohn's disease and ulcerative colitis
Read More
FORUM Pharmaceuticals discloses novel CHRNA7 agonists
Read More
Incyte identifies new TAM kinase inhibitors
Read More
U.S. Dept. of Health & Human Services patents thioredoxin reductase inhibitors
Read More
Memorial Sloan-Kettering presents novel Mcl-1 inhibitors
Read More
Zafgen discovers methionine aminopeptidase 2 inhibitors
Read More
The Broad Institute patents anti-mycobacterial compounds
Read More
Angsana to provide Asian diagnostic screening for STARTRK-2 trial of entrectinib
Read More
Phase I results presented for ANB-020
Read More